- Home
- ATYR vs GDEV Comparison
ATYR vs GDEV Comparison
Compare ATYR & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- GDEV
- Stock Information
- Founded
- ATYR 2005
- GDEV 2009
- Country
- ATYR United States
- GDEV Cyprus
- Employees
- ATYR N/A
- GDEV N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- GDEV EDP Services
- Sector
- ATYR Health Care
- GDEV Technology
- Exchange
- ATYR Nasdaq
- GDEV Nasdaq
- Market Cap
- ATYR 451.3M
- GDEV 384.5M
- IPO Year
- ATYR 2015
- GDEV N/A
- Fundamental
- Price
- ATYR $5.30
- GDEV $16.35
- Analyst Decision
- ATYR Strong Buy
- GDEV Buy
- Analyst Count
- ATYR 6
- GDEV 1
- Target Price
- ATYR $20.20
- GDEV $70.00
- AVG Volume (30 Days)
- ATYR 3.4M
- GDEV 16.2K
- Earning Date
- ATYR 08-12-2025
- GDEV 09-03-2025
- Dividend Yield
- ATYR N/A
- GDEV N/A
- EPS Growth
- ATYR N/A
- GDEV N/A
- EPS
- ATYR N/A
- GDEV 1.38
- Revenue
- ATYR N/A
- GDEV $420,933,000.00
- Revenue This Year
- ATYR $960.85
- GDEV N/A
- Revenue Next Year
- ATYR $1,283.47
- GDEV $17.39
- P/E Ratio
- ATYR N/A
- GDEV $11.56
- Revenue Growth
- ATYR N/A
- GDEV N/A
- 52 Week Low
- ATYR $1.48
- GDEV $8.60
- 52 Week High
- ATYR $5.98
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- ATYR 59.08
- GDEV 48.99
- Support Level
- ATYR $4.96
- GDEV $14.98
- Resistance Level
- ATYR $5.47
- GDEV $16.98
- Average True Range (ATR)
- ATYR 0.38
- GDEV 1.44
- MACD
- ATYR -0.06
- GDEV -0.33
- Stochastic Oscillator
- ATYR 72.22
- GDEV 21.48
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.